Supreme Court Blocks Restrictions on Abortion Pill Mifepristone Until Thursday

The U.S. Supreme Court has temporarily preserved women’s access to mifepristone, a widely used abortion pill, until at least Thursday, June 15, 2023. The justices are reviewing whether to allow restrictions on the drug to take effect.

Justice Samuel Alito issued the order on Monday, June 12, 2023, blocking a federal appeals court’s decision that sought to impose new limitations on mifepristone. The order ensures that women can continue obtaining the pill through pharmacies or by mail without requiring an in-person visit to a doctor.

The Supreme Court’s decision comes amid ongoing legal battles over the regulation of mifepristone, which has been used safely by millions of women in the U.S. since its approval by the FDA in 2000.

Key Details of the Supreme Court’s Order

• Temporary Extension: Access to mifepristone remains unchanged until at least Thursday, June 15, 2023.
• Blocked Restrictions: The order prevents a federal appeals court’s ruling from taking effect, which would have imposed stricter guidelines on the drug’s distribution.
• Current Access: Women can still obtain mifepristone via pharmacies or mail without an in-person doctor visit.

Background on Mifepristone and Legal Challenges

Mifepristone, commonly used in medication abortions, has been a focal point in the national debate over reproductive rights. The FDA approved the drug in 2000, and it has since been used by millions of women in the U.S. However, recent legal challenges have sought to restrict its availability, arguing that the drug poses safety risks.

A federal appeals court had previously ruled to reinstate certain restrictions on mifepristone, including requiring in-person medical visits for its distribution. The Supreme Court’s order temporarily halts these restrictions while the justices deliberate on whether to take up the case for full review.

What’s Next for Mifepristone Access?

The Supreme Court’s decision to extend access to mifepristone provides temporary relief for women and healthcare providers. However, the long-term availability of the drug remains uncertain as the justices weigh whether to allow the federal appeals court’s restrictions to proceed.

If the Supreme Court ultimately allows the restrictions to take effect, women seeking abortions may face additional barriers, including mandatory in-person visits and limited access to the pill through mail-order pharmacies.